Current and Future Immunotherapy Approaches for HCC: Evidence, Guidance, and Resources

Download All
This comprehensive program features expert hepatologist and medical oncologist perspectives on the evolving immunotherapy landscape for HCC, with a focus on multidisciplinary best practices for managing your patients. Watch an on-demand Webcast from a live activity, listen to podcasts, and download the slides for discussion with your colleagues.
Lipika Goyal, MD
David Kaplan, MD, MSc
person default
Thomas Karasic, MD
Amit G. Singal, MD, MS

On-Demand Webcast

Watch this on-demand Webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: November 23, 2021

Watch this on-demand webcast featuring an expert presentation on the use of checkpoint inhibitors in patients with advanced hepatocellular carcinoma. This program specifically focuses on educating hepatologists, medical oncologists, and other members of the multidisciplinary care team.

David Kaplan, MD, MSc person default Thomas Karasic, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 21, 2021 Expired: June 20, 2022

Downloadable Slides

Download this slideset for multidisciplinary expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced HCC.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: September 9, 2020

In this downloadable slideset, experts provide multidisciplinary insights into the optimal use of immune checkpoint inhibitors for advanced HCC.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: April 30, 2021

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with HCC.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: September 14, 2020

Downloadable Resource

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 21, 2021

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: January 22, 2021

In this downloadable PDF transcript from a CCO podcast, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other HCPs in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Released: May 17, 2021

In this downloadable PDF transcript from a CCO podcast, David Kaplan, MD, MSc, and Thomas Karasic, MD, discuss HCP questions focused on current best practices with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Released: June 29, 2021

Podcasts

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, answer audience questions from a series of live CCO Webinars focused on current best practices and emerging applications with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 10, 2020 Expired: December 9, 2021

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, as they provide a succinct discussion of key considerations in the contemporary use of immune checkpoint inhibitors for treating patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: January 19, 2021 Expired: January 18, 2022

Listen to Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations for hepatologists, oncologists, and other healthcare professionals in the contemporary use of immune checkpoint inhibitors for treating specific patient cases with advanced hepatocellular carcinoma.

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 17, 2021 Expired: May 16, 2022

Listen to David Kaplan, MD, MSc, and Thomas Karasic, MD, review approved immunotherapy options for advanced HCC and answer key questions on this topic from a series of live CCO webinars.

David Kaplan, MD, MSc person default Thomas Karasic, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: June 29, 2021 Expired: June 28, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue